P Axelrod|G H Talbot - JoVE Visualize

Showing results (31-40 of 77) with videos related to

Pageof 8

Sort By:

Diagnostic Microbiology and Infectious Disease|May 5, 2000

Characterization of isolates associated with emerging resistance to quinupristin/dalfopristin (Synercid) during a worldwide clinical programM Dowzicky, G H Talbot, C Feger, et al.

Antimicrobial Agents and Chemotherapy|March 1, 1993

Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study GroupG H Talbot, P A Cassileth, L Paradiso, et al.

American Heart Journal|December 1, 1983

Ambulatory ventricular tachycardia: characteristics of the initiating beatB Swerdlow, P Axelrod, B Kolman, et al.

Annals of Internal Medicine|December 1, 1983

Antigen detection in the diagnosis of invasive aspergillosis. Utility in controlled, blinded trialsM H Weiner, G H Talbot, S L Gerson, et al.

American Journal of Infection Control|April 1, 1986

Physiologic, microbiologic, and seasonal effects of handwashing on the skin of health care personnelE Larson, K J McGinley, G L Grove, et al.

Infection Control : IC|February 1, 1986

Physiologic and microbiologic changes in skin related to frequent handwashingE Larson, J J Leyden, K J McGinley, et al.

Clinical Therapeutics|April 22, 1999

Pharmacokinetic interaction of sparfloxacin and digoxinR D Johnson, M B Dorr, T L Hunt, et al.

Journal of Clinical Microbiology|March 1, 1986

Composition and antimicrobic resistance of skin flora in hospitalized and healthy adultsE L Larson, K J McGinley, A R Foglia, et al.

The Journal of Infectious Diseases|April 1, 1986

Skin colonization with antibiotic-resistant (JK group) and antibiotic-sensitive lipophilic diphtheroids in hospitalized and normal adultsE L Larson, K J McGinley, J J Leyden, et al.

The Journal of Antimicrobial Chemotherapy|November 4, 2000

Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study GroupR H Drew, J R Perfect, L Srinath, et al.

Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:

Pageof 8

Diagnostic Microbiology and Infectious Disease|May 5, 2000

Characterization of isolates associated with emerging resistance to quinupristin/dalfopristin (Synercid) during a worldwide clinical programM Dowzicky, G H Talbot, C Feger, et al.

Antimicrobial Agents and Chemotherapy|March 1, 1993

Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study GroupG H Talbot, P A Cassileth, L Paradiso, et al.

American Heart Journal|December 1, 1983

Ambulatory ventricular tachycardia: characteristics of the initiating beatB Swerdlow, P Axelrod, B Kolman, et al.

Annals of Internal Medicine|December 1, 1983

Antigen detection in the diagnosis of invasive aspergillosis. Utility in controlled, blinded trialsM H Weiner, G H Talbot, S L Gerson, et al.

American Journal of Infection Control|April 1, 1986

Physiologic, microbiologic, and seasonal effects of handwashing on the skin of health care personnelE Larson, K J McGinley, G L Grove, et al.

Infection Control : IC|February 1, 1986

Physiologic and microbiologic changes in skin related to frequent handwashingE Larson, J J Leyden, K J McGinley, et al.

Clinical Therapeutics|April 22, 1999

Pharmacokinetic interaction of sparfloxacin and digoxinR D Johnson, M B Dorr, T L Hunt, et al.

Journal of Clinical Microbiology|March 1, 1986

Composition and antimicrobic resistance of skin flora in hospitalized and healthy adultsE L Larson, K J McGinley, A R Foglia, et al.

The Journal of Infectious Diseases|April 1, 1986

Skin colonization with antibiotic-resistant (JK group) and antibiotic-sensitive lipophilic diphtheroids in hospitalized and normal adultsE L Larson, K J McGinley, J J Leyden, et al.

The Journal of Antimicrobial Chemotherapy|November 4, 2000

Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study GroupR H Drew, J R Perfect, L Srinath, et al.

Pageof 8